Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ALX Oncology Holdings Inc. ALXO

Healthcare  —  Biotechnology
1.31 (0.05) (3.68%) as of 25 Sep
Market cap
$187.4M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio — 0.00 0.00 0.00 — — — — —
P/S ratio — 25.44 25.44 653.57 — — — — —
P/FCF ratio — 0.00 0.00 0.00 — — — — —
P/Operating CF — (15.41) (15.41) (117.03) — — — — —
P/B ratio — 0.00 0.00 3.71 — — — — —
Price to Tangible BV — 0.00 0.00 3.71 — — — — —
EV/Sales — 0.67 0.67 477.83 — — — — —
EV/EBITDA — 0.00 0.00 0.00 — — — — —
EV/Operating CF — (0.12) (0.12) (30.43) — — — — —
EV/FCF — (0.12) (0.12) (30.40) — — — — —
Quick Ratio — 4.91 1.92 69.99 23.78 9.43 5.08 6.91 1.82
Current Ratio — 5.45 1.97 70.28 24.00 9.57 5.24 7.26 2.07
Net Debt/EBITDA — 0.62 0.19 10.09 4.32 2.00 0.99 0.81 0.34
Debt/Assets 0.00% 0.00% 50.78% 0.00% 0.68% 3.40% 3.97% 6.70% 16.51%
Debt/Equity — 0.00 (0.08) 0.00 0.01 0.04 0.05 0.09 0.38
Asset Turnover — 0.00 0.90 0.01 0.00 0.00 0.00 0.00 0.00
Operating CF/Net income — 0.76 0.61 0.75 0.82 0.72 0.81 0.90 0.83
Capex/Depreciation — (1.52) (0.80) (0.05) (96.53) 2.58 0.24 0.13 0.83
Interest Coverage — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE — 28.43% 38.02% (28.36%) (21.05%) (39.42%) (70.97%) (88.91%) (145.70%)
ROA — 0.00% (435.95%) (22.81%) (20.45%) (35.97%) (58.58%) (69.10%) (98.34%)
ROIC — 0.00% 0.00% 0.00% (2,661.67%) (1,036.13%) (640.53%) 0.00% 0.00%
Return on Tangible Assets — (187.30%) (409.34%) (11.85%) (23.67%) (50.09%) (102.92%) (113.55%) (371.50%)
Average Days of Receivables — 164.58 40.79 0.00 — 0.00 — — —
Research and Development Expense of Revenue — 545.23% 339.99% 2,450.17% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue — 125.83% 69.08% 1,252.88% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue — 13.01% 6.19% 459.90% 0.00% 0.00% 0.00% 0.00% 0.00%
Graham Net Nets — (0.91) (0.91) 0.27 — — — — —
Graham Number — 0.00 0.00 0.00 — — — — —
Earnings Yield — (28.29%) (28.29%) (8.13%) — — — — —
Free Cash Flow Yield — (22.26%) (22.26%) (2.40%) — — — — —
Revenue per Share — 0.75 1.56 0.06 0.00 0.00 0.00 0.00 0.00
Operating CF per Share — (4.79) (4.63) (2.07) (1.69) (2.19) (3.03) (2.34) (1.57)
Capex per Share — (0.24) (0.11) 0.00 (0.12) (0.04) (0.03) (0.01) 0.00
Free Cash Flow per Share — (5.03) (4.75) (2.07) (1.81) (2.23) (3.06) (2.35) (1.57)
Cash per Share — 3.00 2.93 23.49 9.02 6.54 4.25 2.45 0.83
Shareholders Equity per Share — 0.00 (22.96) 23.25 9.01 6.47 4.41 2.18 0.48
Interest Debt per Share — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share — 0.00 (22.96) 23.25 9.01 6.47 4.41 2.18 0.48
Free Cash Flow — (13.84) (14.60) (38.32) (73.02) (90.65) (131.64) (122.36) (84.35)
Working Capital — 8.34 4.83 429.79 351.72 242.64 152.66 115.85 26.17
Capital Expenditures — (0.65) (0.35) (0.03) (4.92) (1.43) (1.27) (0.45) (0.21)
Net Current Asset Value — 10.21 (71.51) 429.78 349.89 227.94 135.82 100.20 17.66
EV/EBIT — 0.00 0.00 0.00 — — — — —
Capex to Sales — 0.32 0.07 0.03 0.00 0.00 0.00 0.00 0.00
Net Profit Margin — (841.90%) (485.22%) (4,309.81%) 0.00% 0.00% 0.00% 0.00% 0.00%
Price to Operating Income — 0.00 0.00 0.00 — — — — —
Other line items
Depreciation/Fixed assets — 0.45 0.51 11.98 0.06 (0.14) (1.50) (1.21) (0.21)
Cash ROIC — (171.22%) 26.88% (4.44%) (9.46%) (17.24%) (35.06%) (49.67%) (105.99%)
Accounts Receivable Turnover — 2.82 6.53 0.00 — 0.00 — — —
Accounts Payable Turnover — 0.85 1.96 0.57 0.39 0.25 0.00 0.00 0.00
Inventory Turnover — 0.00 0.00 0.00 0.00 0.00 — — —
Average Days of Payables — 135.32 313.77 1.36 1,866.66 2,009.99 0.00 0.00 0.00
Days of Inventory on Hand — 0.00 0.00 0.00 0.00 0.00 — — —
Average Receivables — 0.73 0.73 — — 0.77 — — —
Average Payables — 2.22 2.22 1.88 1.88 5.92 8.33 6.54 4.71
Average Assets — 0.00 5.34 223.37 408.12 343.34 274.52 195.16 103.41
Average Common Equity — (61.21) (61.21) 179.60 396.45 313.26 226.59 151.67 69.80

Fold the line items

Columns are period end dates